The next step, says Dr. Shalev is to create an algorithm that automatically detects suspicious declines in hemoglobin levels, advising doctors to refer patients for further tests. Ideally, he noted, the team at Tel Aviv University will develop a computer program that displays alerts when there is reason for concern.Even if the hemoglobin level can vary each human being as a result of aging, a clear trend was found among study participants who had been diagnosed with colorectal cancer during the study period. About four years before their diagnosis, their blood began to show a continued decline in hemoglobin.
Inbal Goldshtein graduate student working with Dr. Gabriel and Dr. Agnes Varda Chodick Shalev, Tel Aviv University’s School of Public Health and Department of Medical Informatics Maccabi Healthcare Services’, said the emphasis on routine blood tests can be an effective system of screening for colon cancer, if caught early, can be treated effectively. More than 50,000 people in the United States die of colon cancer in 2010. Screening could reduce these numbers significantly improved, Goldshtein said
The advantage of this selection process that may be part of a physical medium. Current tests for colorectal cancer is often costly and unpleasant. There is also a very low rate of compliance among patients, he adds.
Boxers and fighters who do not really head injury was a little ‘better on the second test of the first. But those who have taken serious blows to the head was worse. A cut-off time of 5 seconds worse on the second test identified athletes who failed tests for concussions more intense.
Taking into account the correlation between anemia and colorectal cancer, the team wanted to find out if a lower hemoglobin levels could be detected before the critical stage of the disease – something no scientist had yet tried to quantify. More than 3000 patients with colorectal cancer participated in the study were compared with 10 000 cases of colorectal cancer without controls. Goldshtein and his fellow researchers examined data from blood tests of each participant in a period of ten years, extracted from the computerized database of Maccabi Healthcare Services.
, A common blood disorder characterized by low levels of hemoglobin, has long been associated with those who suffer.
But researchers at Tel Aviv University have discovered that the more a symptom of active disease, low hemoglobin can actually see the potential of years before it is diagnosed.